ActiveGRANT
DoW Ovarian Cancer, Clinical Trial Award
Department of DefenseDept. of the Army -- USAMRAA
AI Overview
This award funds clinical trials for new ovarian cancer treatments, from early proof-of-concept studies through large-scale efficacy trials. It supports evaluation of drugs, biologics, devices, and emerging technologies to improve patient outcomes.
This summary is AI-generated from the official solicitation.
Key Details
Agency
Department of Defense
Funding Amount
—
Release Date
May 4, 2026
Due Date
October 1, 2026
Official Description
<p>Summary: The OCRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of ovarian cancer.</p><p><br></p><p>Distinctive Features: Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first-in...
View on official sourceChange History
Opportunity AddedMay 4, 2026 at 4:44 PM
DoW Ovarian Cancer, Clinical Trial Award
New Grants.gov opportunity: DoW Ovarian Cancer, Clinical Trial Award
Similar Opportunities
Get Alerts for Opportunities Like This
RallyProp monitors thousands of funding sources and sends instant alerts when opportunities match your technology and capabilities.
Start Free Trial